Plasma Therapy Market Size to Reach $698.46 Mn, Globally, by 2030 at 8.50% CAGR

According to the report, the global plasma therapy industry was estimated at $350.21 million in 2020, and is anticipated to hit $698.46 million by 2030, registering a CAGR of 8.50% from 2021 to 2030.

Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/14049

Drivers, restraints, and opportunities-

Increase in geriatric population, rise in prevalence of rare diseases, surge in number of plasma collection centers in the majority of countries, and upsurge in the number of androgenic alopecia patients across the world drive the growth of the global plasma therapy market. On the other hand, high cost of plasma derived products impedes the growth to some extent. However, high growth potential in the emerging economies has been highly beneficial for the market growth.

The pure platelet rich plasma segment to retain the lion's share-

On the basis of type, the pure platelet rich plasma segment held the major share in 2020, garnering nearly three-fifths of the global plasma therapy market. The same segment is projected to cite the fastest CAGR of 9.6% throughout the forecast period, owing to effective results of pure PRP therapies.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/14049

The orthopedics segment to dominate by 2030-

On the basis of application, the orthopedics segment contributed to the lion's share in 2020, holding nearly half of the global plasma therapy market, owing to increase in occurrences of orthopedic disorders such as arthritis and rise in healthcare expenditure among individuals. The same segment is also projected to manifest the fastest CAGR of 9.7% from 2021 to 2030.

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering more than two-fifths of the global plasma therapy market, due to rise in research and developments made by government and private sectors propels the market growth in this region. Simultaneously, the Asia-Pacific region is expected to cite the fastest CAGR of 10.8% throughout the forecast period. Growing population and rise in awareness of blood donation among individuals in this region drive the market growth.

Key players in the industry-

Regen Lab SA
Zimmer Biomet
MTF Biologics
Arthrex
Terumo Corporation
Exactech, Inc.
Ony Biotech Inc.
Johnson & Johnson (DePuy Synthes)
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions'. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.